Targeting MEN1-deficient tumors with DHODH inhibitor

Targeting MEN1-deficient tumors with DHODH inhibitor

Bibliographic Details
Main Author:	Lei Zheng
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Series:	Journal of the National Cancer Center
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667005422000163

Similar Items

A novel mitochondria-targeting DHODH inhibitor induces robust ferroptosis and alleviates immune suppression
by: Yongrui Hai, et al.
Published: (2024-04-01)

Research Progress on Mechanism of Action of DHODH in Progression of Malignant Tumors
by: CHE Xin, et al.
Published: (2024-03-01)

DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
by: Thale Kristin Olsen, et al.
Published: (2022-10-01)

Metabolic Plasticity of Glioblastoma Cells in Response to DHODH Inhibitor BAY2402234 Treatment
by: Ayenachew Bezawork-Geleta, et al.
Published: (2024-07-01)

A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
by: Marcus J. G. W. Ladds, et al.
Published: (2018-03-01)

A targetable PRR11-DHODH axis drives ferroptosis- and temozolomide-resistance in glioblastoma
by: Zong Miao, et al.
Published: (2024-07-01)

A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses
by: Yucheng Zheng, et al.
Published: (2022-04-01)

Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
by: Marcus J. G. W. Ladds, et al.
Published: (2023-08-01)

Cytarabine-induced differentiation of AML cells depends on Chk1 activation and shares the mechanism with inhibitors of DHODH and pyrimidine synthesis
by: Barbara Tomic, et al.
Published: (2022-07-01)

DHODH modulates transcriptional elongation in the neural crest and melanoma
by: White, Richard Mark, et al.
Published: (2014)

The Warburg effect modulates DHODH role in ferroptosis: a review
by: Alvan Amos, et al.
Published: (2023-05-01)

PACS2/CPT1A/DHODH signaling promotes cardiomyocyte ferroptosis in diabetic cardiomyopathy
by: Hong Xiang, et al.
Published: (2024-12-01)

Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement
by: Lin Liu, et al.
Published: (2024-06-01)

Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
by: Rui Xiong, et al.
Published: (2020-08-01)

The Novel <i>h</i>DHODH Inhibitor MEDS433 Prevents Influenza Virus Replication by Blocking Pyrimidine Biosynthesis
by: Giulia Sibille, et al.
Published: (2022-10-01)

Intraocular DHODH-inhibitor PP-001 suppresses relapsing experimental uveitis and cytokine production of human lymphocytes, but not of RPE cells
by: Maria Diedrichs-Möhring, et al.
Published: (2018-02-01)

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
by: Rui Xiong, et al.
Published: (2020-10-01)

Targeting both the enzymatic and non-enzymatic functions of DHODH as a therapeutic vulnerability in c-Myc-driven cancer
by: Qiang Zhang, et al.
Published: (2025-03-01)

A new small molecule DHODH-inhibitor [KIO-100 (PP-001)] targeting activated T cells for intraocular treatment of uveitis — A phase I clinical trial
by: Stephan Thurau, et al.
Published: (2022-10-01)

P1280: TARGETED INHIBITION OF DHODH IS SYNERGISTIC WITH BCL2 BLOCKADE IN LYMPHOMA WITH CONCURRENT MYC AND BCL2 REARRANGEMENT
by: W. Mo, et al.
Published: (2022-06-01)

DHODH Alleviates Heart Failure via the Modulation of CoQ-Related Ferroptotic Inhibition
by: Chen Wang, et al.
Published: (2024-07-01)

PCK1 and DHODH drive colorectal cancer liver metastatic colonization and hypoxic growth by promoting nucleotide synthesis
by: Norihiro Yamaguchi, et al.
Published: (2019-12-01)

The Elephant and the Blind Men: Making Sense of PARP Inhibitors in Homologous Recombination Deficient Tumor Cells
by: Silvana eDe Lorenzo, et al.
Published: (2013-09-01)

Structure-based scoring of anthocyanins and molecular modeling of PfLDH, PfDHODH, and PfDHFR reveal novel potential P. falciparum inhibitors
by: Precious A. Akinnusi, et al.
Published: (2023-01-01)

DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
by: Nicholas J Mullen, et al.
Published: (2024-07-01)

The New Generation <i>h</i>DHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses
by: Arianna Calistri, et al.
Published: (2021-08-01)

Caffeic Acid Phenethyl Ester as a DHODH Inhibitor and Its Synergistic Anticancer Properties in Combination with 5-Fluorouracil in a Breast Cancer Cell Line
by: Amalia E, et al.
Published: (2022-07-01)

Bioinformatics analysis and experimental verification of the cancer-promoting effect of DHODH in clear cell renal cell carcinoma
by: Songsong Wang, et al.
Published: (2024-05-01)

Assessment of a novel variation in DHODH gene causing Miller syndrome: The first report in Chinese population
by: Kai Yang, et al.
Published: (2023-07-01)

In-silico studies of hydroxyxanthone derivatives as potential pfDHFR and pfDHODH inhibitor by molecular docking, molecular dynamics simulation, MM-PBSA calculation and pharmacokinetics prediction
by: Lathifah Puji Hastuti, et al.
Published: (2024-01-01)

IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro
by: Friedrich Hahn, et al.
Published: (2020-12-01)

Depletion of SOD2 enhances nasopharyngeal carcinoma cell radiosensitivity via ferroptosis induction modulated by DHODH inhibition
by: Alvan Amos, et al.
Published: (2023-02-01)

17β-oestradiol inhibits ferroptosis in the hippocampus by upregulating DHODH and further improves memory decline after ovariectomy
by: Ying Tian, et al.
Published: (2023-06-01)

Virtual screening and molecular dynamic simulations of the antimalarial derivatives of 2-anilino 4-amino substituted quinazolines docked against a Pf-DHODH protein target
by: Zakari Ya’u Ibrahim, et al.
Published: (2022-08-01)

Computer-aided discovery of novel SmDHODH inhibitors for schistosomiasis therapy: Ligand-based drug design, molecular docking, molecular dynamic simulations, drug-likeness, and ADMET studies.
by: Saudatu Chinade Ja'afaru, et al.
Published: (2024-09-01)

A pharmacokinetic drug–drug interaction study between rosuvastatin and emvododstat, a potent anti‐SARS‐CoV‐2 (COVID‐19) DHODH (dihydroorotate dehydrogenase) inhibitor
by: Terri L. Morton, et al.
Published: (2023-04-01)

Mitochondrial Dysfunction‐Evoked DHODH Acetylation is Involved in Renal Cell Ferroptosis during Cisplatin‐Induced Acute Kidney Injury
by: Nan‐Nan Liang, et al.
Published: (2024-11-01)

Correction: Depletion of SOD2 enhances nasopharyngeal carcinoma cell radiosensitivity via ferroptosis induction modulated by DHODH inhibition
by: Alvan Amos, et al.
Published: (2023-05-01)

Targeting BRCA2 deficiency with GSK3 inhibitors
by: Zonderland, G
Published: (2017)

Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
by: Tacconi, E, et al.
Published: (2019)